Public offering

Heron Therapeutics Announces Proposed Public Offering of Common Stock

Retrieved on:

Thursday, October 3, 2019

Finance, Financial markets, Money, Stock market, Corporate finance, Equity securities, Public offering, Stock, Underwriting, Security, Offering, Share

Heron intends to grant the underwriters of the offering a 30-day option to purchase up to an additional 15% of the shares sold in the public offering.

Key Points:

Heron intends to grant the underwriters of the offering a 30-day option to purchase up to an additional 15% of the shares sold in the public offering.
All of the shares of common stock in the offering are to be sold by Heron.
The offering is subject to market conditions, and there can be no assurance as to whether or when the offering may be completed, or the actual size or terms of the offering.
Cantor is acting as lead manager for the offering, and JMP Securities, Needham & Company and Northland Capital Markets are acting as co-managers for the offering.

Frequency Therapeutics Announces Pricing of Initial Public Offering

Retrieved on:

Thursday, October 3, 2019

Biotechnology, Health, Pharmaceutical, Clinical trials, Finance, Financial markets, Money, Initial public offering, Corporate finance, Stock market, Underwriting, Public offering, Offering, NASDAQ, Stock, Underwriting spread

Frequency Therapeutics, Inc. (Nasdaq: FREQ), a clinical-stage biotechnology company focused on harnessing the bodys innate biology to repair or reverse damage caused by a broad range of degenerative diseases, today announced the pricing of its initial public offering of 6,000,000 shares of common stock at a public offering price of $14.00 per share, for total gross proceeds of approximately $84.0 million, before deducting underwriting discounts and commissions.

Key Points:

Frequency Therapeutics, Inc. (Nasdaq: FREQ), a clinical-stage biotechnology company focused on harnessing the bodys innate biology to repair or reverse damage caused by a broad range of degenerative diseases, today announced the pricing of its initial public offering of 6,000,000 shares of common stock at a public offering price of $14.00 per share, for total gross proceeds of approximately $84.0 million, before deducting underwriting discounts and commissions.
In addition, Frequency has granted the underwriters a 30-day option to purchase up to an additional 900,000 shares of its common stock at the initial public offering price less the underwriting discounts and commissions.
J.P. Morgan, Goldman Sachs & Co. LLC and Cowen are acting as joint book-running managers for the offering.
A registration statement relating to the securities being sold in the offering has been declared effective by the Securities and Exchange Commission.

MetroCity Bankshares, Inc. Prices Initial Public Offering of its Common Stock

Retrieved on:

Thursday, October 3, 2019

Finance, Financial markets, Money, Stock market, Corporate finance, Underwriting, Initial public offering, Stock, Public offering, Shareholder

ATLANTA, Ga., Oct. 02, 2019 (GLOBE NEWSWIRE) -- MetroCity Bankshares, Inc. (MetroCity), the bank holding company for Metro City Bank, announced today the pricing of its initial public offering of 1,939,000 shares of common stock at a price to the public of $13.50 per share.

Key Points:

ATLANTA, Ga., Oct. 02, 2019 (GLOBE NEWSWIRE) -- MetroCity Bankshares, Inc. (MetroCity), the bank holding company for Metro City Bank, announced today the pricing of its initial public offering of 1,939,000 shares of common stock at a price to the public of $13.50 per share.
MetroCity is offering 1,000,000 of the shares and the selling shareholders are offering 939,000 of the shares.
In addition, MetroCity has granted the underwriters a 30-day option to purchase up to 290,850 additional shares of MetroCity common stock at the initial public offering price, less underwriting discounts.
This press release contains certain forward-looking statements, including statements with regard to MetroCitys completion of its initial public offering.

Shareholder Alert: Robbins Arroyo LLP is Investigating Aptinyx Inc. (APTX) on Behalf of Shareholders

Retrieved on:

Wednesday, October 2, 2019

Legal, Professional services, Initial public offering, Economy, Finance, Money, Corporate finance, Financial markets, Public offering

Shareholder rights law firm Robbins Arroyo LLP informs shareholders that it is investigating Aptinyx Inc. (NYSE: APTX) for potential violations of securities laws pursuant to its June 2018 initial public offering ("IPO").

Key Points:

Shareholder rights law firm Robbins Arroyo LLP informs shareholders that it is investigating Aptinyx Inc. (NYSE: APTX) for potential violations of securities laws pursuant to its June 2018 initial public offering ("IPO").
Aptinyx completed its IPO on June 21, 2018, offering $16.00 per share for net proceeds of $92.2 million.
Aptinyx is a clinical-stage biopharmaceutical company that focuses on the discovery, development, and commercialization of synthetic molecules for the treatment of brain and nervous system disorders.
If you suffered a loss as a result of Aptinyx stock, click here .

Digital Realty Announces Pricing Of Preferred Stock Offering

Retrieved on:

Tuesday, October 1, 2019

Finance, Money, Economy, Initial public offering, Financial markets, Stock market, U.S. Securities and Exchange Commission, Shelf registration, Prospectus, Registration statement, Public offering, Security

The preferred stock offering is expected to close on October 10, 2019, subject to customary closing conditions.

Key Points:

The preferred stock offering is expected to close on October 10, 2019, subject to customary closing conditions.
BofA Securities, Inc., Morgan Stanley & Co. LLC, UBS Securities LLC and Wells Fargo Securities, LLC are the joint book-running managers for the preferred stock offering.
The preferred stock offering was made under an effective shelf registration statement filed with the Securities and Exchange Commission.
A copy of the preliminary prospectus supplement, final prospectus supplement (when available), and the accompanying prospectus relating to the offering of the preferred stock may be obtained by contacting:

Predictive Oncology Inc. Announces Proposed Public Offering of Common Stock

Retrieved on:

Tuesday, October 1, 2019

Finance, Money, Corporate finance, Economy, Initial public offering, Equity securities, Offering, Public offering, Warrant, NASDAQ, Forward-looking statement

MINNEAPOLIS, Oct. 01, 2019 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) (Predictive or the Company) today announced a proposed public offering of its common stock.

Key Points:

MINNEAPOLIS, Oct. 01, 2019 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) (Predictive or the Company) today announced a proposed public offering of its common stock.
Dawson James Securities, Inc. and Paulson Investment Company, LLC are acting as exclusive placement agents for the offering.
Predictive intends to use the net proceeds from the offering, if completed, for working capital and general corporate purposes.
This press release contains forward-looking statements, including statements related to Predictives public offering of common stock and warrants and the completion of the offering that involve risks and uncertainties.

HBT Financial Announces Launch of Initial Public Offering

Retrieved on:

Tuesday, October 1, 2019

Finance, Money, Financial markets, Initial public offering, Corporate finance, Stock market, Underwriting, Stock, Public offering, HBT

BLOOMINGTON, Ill., Oct. 01, 2019 (GLOBE NEWSWIRE) -- HBT Financial, Inc. (HBT), the holding company for Heartland Bank and Trust Company and State Bank of Lincoln, today announced that it has launched the initial public offering of 8,300,000 shares of its common stock.

Key Points:

BLOOMINGTON, Ill., Oct. 01, 2019 (GLOBE NEWSWIRE) -- HBT Financial, Inc. (HBT), the holding company for Heartland Bank and Trust Company and State Bank of Lincoln, today announced that it has launched the initial public offering of 8,300,000 shares of its common stock.
The underwriters will have a 30-day option to purchase an additional 1,245,000 shares from HBT at the initial public offering price, less underwriting discounts and commissions.
The initial public offering price is expected to be between $17.00 and 19.00 per share.
HBT expects to list its common stock on the Nasdaq Global Select Market under the trading symbol HBT.

Plymouth Industrial REIT Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares

Retrieved on:

Monday, September 30, 2019

Commercial Building & Real Estate, Construction & Property, REIT, Initial public offering, Finance, Money, Economy, Prospectus, Public offering, Real estate investment trust

Plymouth Industrial REIT, Inc. (NYSE American: PLYM) (the Company) today announced the closing of its previously announced public offering of common stock.

Key Points:

Plymouth Industrial REIT, Inc. (NYSE American: PLYM) (the Company) today announced the closing of its previously announced public offering of common stock.
The Company issued 3,450,000 shares, including 450,000 shares pursuant to the full exercise of the underwriters option to purchase additional shares.
Barclays, KeyBanc Capital Markets and J.P. Morgan acted as joint book-running managers for the offering.
A final prospectus supplement, dated September 25, 2019, relating to the offering was filed with the Securities and Exchange Commission.

Fortis Minerals Files Registration Statement for Proposed Initial Public Offering

Retrieved on:

Monday, September 30, 2019

Fortis Minerals, LLC (Fortis Minerals) today announced that it has publicly filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (SEC) relating to a proposed initial public offering of its Class A shares.

Key Points:

Fortis Minerals, LLC (Fortis Minerals) today announced that it has publicly filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (SEC) relating to a proposed initial public offering of its Class A shares.
The number of shares to be offered and the price range for the proposed offering have not yet been determined.
Fortis Minerals intends to list its Class A shares on the New York Stock Exchange under the ticker symbol NRI.
The proposed offering will be made only by means of a prospectus.

Glancy Prongay & Murray Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Greenlane Holdings, Inc.

Retrieved on:

Monday, September 30, 2019

Finance, Economy, Money, Initial public offering, Public offering

In April 2019, the Company held its initial public offering (IPO) in which it sold more than 6 million common shares at $17.00 per share.

Key Points:

In April 2019, the Company held its initial public offering (IPO) in which it sold more than 6 million common shares at $17.00 per share.
Since the IPO, shares of Greenlane has traded as low as $5.39, a nearly 68% decline from the $17 per share IPO price.
To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action.
Glancy Prongay & Murray LLP, Los Angeles